Posted September 16, 2019

The Scientists

  • Dr. Srinand Sreevatsan, professor and associate dean of Research and Graduate Studies, MSU College of Veterinary Medicine
  • Dr. Kelly Straka, section supervisor and laboratory scientist, MDNR Wildlife Disease Laboratory
  • Dr. Rachel Reams, director, MSU Veterinary Diagnostic Laboratory
  • Dr. Steve Bolin, professor, Department of Pathobiology and Diagnostic Investigation, MSU College of Veterinary Medicine

Four scientists closely connected to the MSU College of Veterinary Medicine were awarded $916,023 for their three-year project that focuses on the screening and diagnosis of chronic wasting disease (CWD) in deer. The project, titled “CWD: Field Animal-Side Testing and Improving Laboratory Diagnostic Sensitivity,” is funded jointly by Michigan State University and the Michigan Department of Natural Resources.

Current technology used for CWD screening and diagnosis is slow and sometimes less sensitive; it’s based on detection of prion protein aggregates using an antibody. The testing also takes place in a lab, which means it is labor-intensive. Drs. Srinand Sreevatsan, Kelly Straka, Rachel Reams, and Steve Bolin will investigate a different technology—RT-QuIC—as a faster and more accurate testing method.

“We have a unique opportunity to use the experience of the DNR and MSU on the biology of CWD and in test development, as well as access to samples and current ‘gold standard tests’ to create a new solution for CWD screening and testing,” says Reams.

“CWD is a prion disease, which means misfolded host proteins lead to neurological damage,” explains Sreevatsan. “Instead of using a test based on detection of protease-resistant prions using antibodies like ELISA, we are going to use RT-QuIC to amplify the misfolded protein in suspect tissue samples. This will offer us better detection and sensitivity in real time as misfolded proteins accumulate.”

Another aspect of this study is to detect biomarkers that accumulate in blood (as a result of neurological damage) as a screening test in the field. This approach would facilitate deer screening in the field for the neuronal proteins. That means testing will be fast and easy for captive deer farmers and wild deer hunters, and only deer triggering positive for potential brain damage would be sent to the laboratory for RT-QuIC testing.

This is especially important because clinical signs of CWD don’t present until the later stages of the disease, after the infected deer has had plenty of opportunity to spread the disease to other animals and throughout the environment. The new protocol would encourage testing to protect animal health, as well as provide faster data for health officials and natural resource protection agencies to help slow the spread of CWD throughout the environment.

“This is a conservation effort,” says Sreevatsan. “We want to protect our environment and the animals who live in it, as well as the tradition of hunting.”

During the first year of their project, scientists will develop RT-QuIC and investigate specific biomarkers that indicate CWD. They will use these results to develop a rapid field test to detect CWD in free-ranging and hunted deer during the second and third years of the project.

For more information, contact Dr. Srinand Sreevatsan.